These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35592415)

  • 21. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research.
    Richardson M; Moore DA; Gwernan-Jones R; Thompson-Coon J; Ukoumunne O; Rogers M; Whear R; Newlove-Delgado TV; Logan S; Morris C; Taylor E; Cooper P; Stein K; Garside R; Ford TJ
    Health Technol Assess; 2015 Jun; 19(45):1-470. PubMed ID: 26129788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Storm MRO; Pereira Ribeiro J; Skoog M; Groth C; Callesen HE; Schaug JP; Darling Rasmussen P; Huus CL; Zwi M; Kirubakaran R; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009885. PubMed ID: 36971690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.
    Storebø OJ; Skoog M; Damm D; Thomsen PH; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008223. PubMed ID: 22161422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative Treatments to Pharmacological Therapy in Pediatric Populations With Attention-Deficit/Hyperactivity Disorder (ADHD): A Scoping Review.
    Leon L; Tran T; Navadia M; Patel J; Vanderveen A; Cruz MI; Le TM; Assuah FB; Prager V; Patel D; Costin JM
    Cureus; 2024 Mar; 16(3):e55792. PubMed ID: 38586804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.
    Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.
    Benkert D; Krause KH; Wasem J; Aidelsburger P
    GMS Health Technol Assess; 2010 Sep; 6():Doc13. PubMed ID: 21289886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylphenidate for children and adolescents with autism spectrum disorder.
    Sturman N; Deckx L; van Driel ML
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative treatments for attention-deficit/hyperactivity disorder: does evidence support their use?
    Brue AW; Oakland TD
    Altern Ther Health Med; 2002; 8(1):68-70, 72-4. PubMed ID: 11795624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
    Chan E; Fogler JM; Hammerness PG
    JAMA; 2016 May; 315(18):1997-2008. PubMed ID: 27163988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pine bark (Pinus spp.) extract for treating chronic disorders.
    Robertson NU; Schoonees A; Brand A; Visser J
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD008294. PubMed ID: 32990945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attention-deficit/hyperactivity disorder and inflammation: natural product-derived treatments-a review of the last ten years.
    Martins A; Conte M; Goettert MI; Contini V
    Inflammopharmacology; 2023 Dec; 31(6):2939-2954. PubMed ID: 37740887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents.
    Bjornstad G; Montgomery P
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005042. PubMed ID: 15846741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta-analysis.
    Patra S; Nebhinani N; Viswanathan A; Kirubakaran R
    Autism Res; 2019 Apr; 12(4):542-552. PubMed ID: 30653855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.
    Zwi M; Jones H; Thorgaard C; York A; Dennis JA
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003018. PubMed ID: 22161373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831).
    Kean JD; Kaufman J; Lomas J; Goh A; White D; Simpson D; Scholey A; Singh H; Sarris J; Zangara A; Stough C
    Nutrients; 2015 Dec; 7(12):9931-45. PubMed ID: 26633481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST; Steeves TD; Pringsheim T
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D;
    BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of Rosa canina L. and a polyherbal formulation syrup in patients with attention-deficit/hyperactivity disorder: a study protocol for a multicenter randomized controlled trial.
    Golsorkhi H; Qorbani M; Kamalinejad M; Sabbaghzadegan S; Bahrami M; Vafaee-Shahi M; Montazerlotfelahi H; Abniki E; Dadmehr M
    Trials; 2022 May; 23(1):434. PubMed ID: 35606864
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.